71 — 9 (47) 2022 — Ahmedova N.Sh., Saidov F.A., NEPHROPATHY ASSOCIATED WITH COVID-19, CLINICAL AND DIAGNOSTIC ASPECTS

NEPHROPATHY ASSOCIATED WITH COVID-19, CLINICAL AND DIAGNOSTIC ASPECTS

Ahmedova N.Sh., Bukhara State Medical Institute

Saidov F.A., Bukhara State Medical Institute

Resume

At present, it has become obvious that with the development of COVID-19, there is a multisystemic lesion. The immunopathological process involves blood vessels and the blood coagulation system with damage to the lungs, heart, nervous and endocrine systems. It was thought that the kidneys were involved to a lesser extent, but according to the latest data, acute renal failure with the need for dialysis. COVID-19 can affect the kidneys in different ways, and the contribution of these factors may change over time.

Keywords. COVID-19, kidneys, nephropathy, CKD

First page

424

Last page

427

For citation: Ahmedova N.Sh., Saidov F.A., NEPHROPATHY ASSOCIATED WITH COVID-19, CLINICAL AND DIAGNOSTIC ASPECTS //New Day in Medicine 9 (47)2022 424-427 https://l.clck.bar/b3db5

LIST OF REFERENCES:

  1. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis / X. Wang [et al.] // Research (Wash D C). – 2020 Apr. – Vol. 2020. – 2020:2402961.
  2. COVID-19 and Older Adults: What We Know / Z. Shahid [et al.] // J. Am. Geriatr. Soc. – 2020 May. – Vol. 68, N 5. – P. 926-929.
  3. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup / M. K. Nadim [et al.] // Nat. Rev. Nephrol. – 2020 Dec. – Vol. 16. – P. 747-764.
  4. Glenn, D. A. et al. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease. // Kidney Int. Rep. 6, 1407–1410 (2021).
  5. Henry, B. M. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection / B. M. Henry, G. Lippi // Int. Urol. Nephrol. – 2020. – Vol. 52, N 6. P. 1193-1194
  6. International Society of Nephrology (ISN) [Electronic resource]. – Mode of access: https://www.theisn.org/covid-19.
  7. Kho, M. M. L. et al. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant. // Nephrol. Dial. Transpl. 36, 1761–1764 (2021).
  8. Oyelade, T. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis / T. Oyelade, J. Alqahtani, G. Canciani // Trop. Med. Infect. Dis. – 2020 May. – Vol. 5, N. 2. – P. 80.
  9. Qin, C. X. et al. Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. // Transplantation 105, e265–e266 (2021).
  10. Ravanan, R. et al. Two doses of SARS-CoV-2 vaccines reduce risk of death due to COVID-19 in solid organ transplant recipients: preliminary outcomes from a UK registry linkage analysis. // Transplantation 105, e263–e264 (2021).
  11. Windpessl, M. et al. COVID-19 vaccines and kidney disease. // Nat. Rev. Nephrol. 17, 291–293 (2021).

file

download